Growth Hormone Axis

CJC-1295 no DAC 5mg + Ipamorelin 5mg

Name: CJC-1295 no DAC 5mg + Ipamorelin 5mg - Fraction Research
Price: 59.99 USD
Availability: InStock

$59.99

Lot verification pending publication for this compound

Research blend of CJC-1295 (no DAC) and Ipamorelin in equal parts

Form: Lyophilized
Purity: ≥99% by HPLC-UV

Cold-Packed Protected seasonal packaging

Dispatches ≤48hr From Columbia, SC

Lot Verified COA included with every order

Independently Tested HPLC-UV verified, every single lot

Lot-traceable — matched to a public Certificate of Analysis

Research Use Only — not for human or veterinary use

View Certificate of Analysis

What You Receive

1× Research Vial

CJC-1295 no DAC 5mg + Ipamorelin 5mg — nominal content per selected size
Lyophilized
Tamper-evident seal
Lot-numbered label
Lot-matched Certificate of Analysis

Verification

Current Lot & Certificate of Analysis

Lot verification data for this compound hasn’t been published to the COA Library yet.

Browse the COA Library

Specifications

Technical Specifications

Physical Form Lyophilized

Purity Specification ≥99% by HPLC-UV

Analytical Method HPLC-UV, 218nm

Research Context

Research Overview

This combination research product contains equal parts CJC-1295 (without DAC) and Ipamorelin co-lyophilized in a single vial. CJC-1295 (no DAC) is a synthetic 29-amino acid GHRH analog (CAS 863288-34-0, MW 3357.88 g/mol). Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (CAS 170851-70-4, MW 711.85 g/mol). Each vial is labeled with the total mass and the component breakdown.
These two peptides act at distinct receptors in the growth hormone axis. CJC-1295 (no DAC) acts as a GHRH receptor agonist at pituitary somatotroph cells. Ipamorelin acts as a selective agonist at the ghrelin receptor (GHS-R1a). Research utilizing both peptides in combination allows investigators to study the complementary or additive effects on in-vitro GH secretion models, somatotroph signaling, and receptor co-stimulation dynamics — areas of active investigation in hypothalamic-pituitary axis research.
Each component is independently tested by HPLC-UV prior to blending, with a minimum purity threshold of ≥99.0% for each. Combined molecular identity confirmed by LC-MS. Certificate of Analysis available for every lot number.
For laboratory and in-vitro research use only. Not for human or veterinary use. Not FDA approved.

References

Peer-reviewed literature references for this compound are being compiled and will be published here.

Documentation

Technical Documentation

COA Certificate of Analysis View in COA Library TDS Technical Data Sheet PDF SDS Safety Data Sheet PDF

Fulfillment

Fulfillment & Packaging

Ships From

Columbia, South Carolina

Dispatch Timeframe

Within 48 hours of order confirmation

Cold-Chain Packaging

Insulated, seasonally adjusted packaging protects material in transit

Tamper-Evident Vial

Every vial ships sealed and lot-labeled

Shipping Area

Domestic (U.S.) shipping only

Shipping Cost

Calculated at checkout — see the Shipping Policy for full details

Questions

Frequently Asked Questions

Is this lot independently tested?

Yes. Every lot is tested by an independent third-party laboratory using HPLC-UV before it is released for sale, and results are published in the COA Library.

How do I locate my lot's Certificate of Analysis?

Use the "View Certificate of Analysis" link on this page, or search the COA Library directly by compound name or the lot number printed on your vial label.

What analytical methods are used?

Purity is determined by HPLC-UV. Molecular identity is confirmed by LC-MS prior to release.

How is the material packaged?

Material ships in a tamper-evident, lot-labeled vial inside cold-chain packaging appropriate for the season.

What does "Research Use Only" mean?

This product is sold exclusively for laboratory and in-vitro research applications by qualified researchers. It is not a drug, dietary supplement, or approved for human or veterinary use.